ASTRAZENECA PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.66 USD | -0.18% |
|
+2.39% | +17.12% |
| 04:02pm | AstraZeneca: licensing agreement signed with Nona Biosciences | CF |
| 06:21am | HBM Holdings Unit, AstraZeneca Sign License, Option Agreement for Targeted Cancer Treatment; Shares Rise 16% | MT |
ETFs positioned on AstraZeneca PLC
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.38% | 9 M€ | -4.31% | - | |
| 0.99% | 1,100 M€ | +4.55% | ||
| 0.77% | 265 M€ | +6.12% | - | |
| 0.44% | 17 M€ | 0.00% | ||
| 0.43% | 1,083 M€ | +3.76% | ||
| 0.38% | 3 M€ | 0.00% | - | |
| 0.32% | 15 M€ | 0.00% | - | |
| 0.15% | 368 M€ | +24.10% | - | |
| 0.09% | 17 M€ | +5.12% | - | |
| 0.04% | 85 M€ | +14.63% | - | |
| 0.04% | 9 M€ | +10.49% | - | |
| 0.03% | 15 M€ | -1.62% | - | |
| 0.03% | 1,487 M€ | +8.50% | - | |
| 0.03% | 2 M€ | +3.16% | - | |
| 0.02% | 756 M€ | +0.29% | - | |
| 0.01% | 234 M€ | +8.58% | - | |
| 4.53% | 28 M€ | +8.95% | - |
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
Pharmaceuticals
Calendar
2024-06-03
- Investor Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
157.3
USD
Average target price
169.7
USD
Spread / Average Target
+7.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +39.63% | 723B | |
| +34.28% | 595B | |
| -4.15% | 369B | |
| +20.29% | 332B | |
| +2.83% | 282B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| +0.07% | 168B | |
| +7.59% | 166B |
- Stock Market
- Equities
- AZN Stock
- AZN Stock
- Funds and ETFs AstraZeneca PLC
